faron pharmaceuticals' markku jalkanen 'excited' to be advancing clevegen
Published 7 years ago • 170 plays • Length 3:22Download video MP4
Download video MP3
Similar videos
-
22:47
faron pharmaceuticals' markku jalkanen presents at the biotech capital conference
-
3:23
faron pharmaceuticals ceo on benefits of innovation passport for cancer immunotherapy
-
3:24
faron pharmaceuticals ceo delighted with latest bexmab study findings
-
30:10
faron pharmaceuticals' present to investors at the proactive one2one live virtual forum
-
29:19
faron pharmaceuticals oy (aim:farn) (otc:fphaf) proactive one2one virtual forum - 27th january 2022
-
5:19
cramer: this biotech stock could be worth over $100 billion on an fda approval
-
4:56
faron pharmaceuticals cmo discusses positive read-out from phase ii trial of lead asset
-
13:05
faron pharmaceuticals sijoituskohteena | sijoittajapäivä 15.11.2021
-
7:01
faron pharma to take clevegen cancer candidate into the clinic this year
-
6:16
faron pharmaceuticals' present 'groundbreaking' results from bexmarilimab cancer treatment trial
-
8:41
faron pharma updates on clevegen development as partner discussions advance
-
0:59
faron pharmaceuticals - proactive one2one investor forum may 2019
-
6:33
faron pharmaceuticals oy excited by green light for trials of promising anti-cancer treatment
-
7:09
faron pharmaceuticals oy trying to accelerate programmes 'as fast as we can'
-
3:19
faron pharmaceuticals boss says patent protection is very significant step
-
6:36
faron pharmaceuticals' new ceo dr juho jalkanen sets bold vision for 2024
-
19:23
faron pharmaceuticals' clever-1 immunotherapy and cancer treatment hope - proactive one2one forum
-
3:23
faron pharmaceuticals initiates second phase of bexmab study
-
4:56
faron pharma to expand its clevegen trial to focus on colorectal cancer
-
4:57
it’s a “very exciting” time for faron pharmaceutical as aml study advances
-
5:50
faron pharmaceuticals chief medical officer marie-louise fjällskog presents work with bexmarilimab